In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus
Qianran Wang(Chinese Academy of Sciences), Zhìhóng Hú(East China University of Science and Technology), Yunzheng Yan, Wu Zhong(National Institutes for Food and Drug Control), Ruiyuan Cao, Linjie Yan, Liushuai Li(Chinese Academy of Sciences), Wei Li(Shanghai Sixth People's Hospital), Yanming Wang, Jingjing Yang, Li Jiang(Children's Hospital of Chongqing Medical University), Manli Wang(Chinese Academy of Sciences), Fēi Dèng(Hubei University of Medicine), Jia Liu(Tongji University), Yiwu Zhou(Zhejiang Gongshang University)
Cited by 26
Related Papers
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
|Science China Life Sciences|2020|2.3k
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|405
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation
|Signal Transduction and Targeted Therapy|2020|391
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
|Cell Research|2020|251